The DOI matches its Crossref record; 318 of the 318 references it cites were found in a registry or an index.
Deubiquitinase inhibition as a cancer therapeutic strategy
Open accessAbstract
The ubiquitin proteasome system (UPS) is the main system for controlled protein degradation and a key regulator of fundamental cellular processes. The dependency of cancer cells on a functioning UPS has made this an attractive target for development of drugs that show selectivity for tumor cells. Deubiquitinases (DUBs, ubiquitin isopeptidases) are components of the UPS that catalyze the removal of ubiquitin moieties from target proteins or polyubiquitin chains, resulting in altered signaling or changes in protein stability. A number of DUBs regulate processes associated with cell proliferation and apoptosis, and as such represent candidate targets for cancer therapeutics. The majority of DUBs are cysteine proteases and are likely to be more "druggable" than E3 ligases. Cysteine residues in the active sites of DUBs are expected to be reactive to various electrophiles. Various compounds containing α,β-unsaturated ketones have indeed been demonstrated to inhibit cellular DUB activity. Inhibition of proteasomal cysteine DUB enzymes (i.e. USP14 and UCHL5) can be predicted to be particularly cytotoxic to cancer cells as it leads to blocking of proteasome function and accumulation of proteasomal substrates. We here provide an overall review of DUBs relevant to cancer and of various small molecules which have been demonstrated to inhibit DUB activity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Selective killing of cancer cells by a small molecule targeting the stress response to ROS
Raj, L., Ide, T., Gurkar, A. U., Foley, M., Schenone, M., Li, X., Tolliday, N. J., Golub, T. R., Carr, S. A., Shamji, A. F., et al. (2011) · Nature · doi:10.1038/nature10167 · Cited by 1,030
RetractedHershko, A., & Ciechanover, A. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.425 · Cited by 8,840
Bioavailability of curcumin: Problems and promises
Anand, P., Kunnumakkara, A. B., Newman, R. A., & Aggarwal, B. B. (2007) · Molecular Pharmaceutics · doi:10.1021/mp700113r · Cited by 5,543 · cited 2×
“Curcumin is safe to humans at doses of 12 g/day but exhibits poor bioavailability (Anand et al., 2007).”
BackgroundLamb, J., Crawford, E. D., Peck, D., Modell, J. W., Blat, I. C., Wrobel, M. J., Lerner, J., Brunet, J.-P., Subramanian, A., Ross, K. N., et al. (2006) · Science · doi:10.1126/science.1132939 · Cited by 5,257
hSIR2SIRT1 Functions as an NAD-Dependent p53 Deacetylase
Vaziri, H., Dessain, S. K., Eaton, E. N., Imai, S.-I., Frye, R. A., Pandita, T. K., Guarente, L., & Weinberg, R. A. (2001) · Cell · doi:10.1016/s0092-8674(01)00527-x · Cited by 2,659
Rock, K. L., Gramm, C., Rothstein, L., Clark, K., Stein, R., Dick, L., Hwang, D., & Goldberg, A. L. (1994) · Cell · doi:10.1016/s0092-8674(94)90462-6 · Cited by 2,524
STRUCTURE AND FUNCTIONS OF THE 20S AND 26S PROTEASOMES
Coux, O., Tanaka, K., & Goldberg, A. L. (1996) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.65.070196.004101 · Cited by 2,487
Structure of 20S proteasome from yeast at 2.4Å resolution
Groll, M., Ditzel, L., Löwe, J., Stock, D., Bochtler, M., Bartunik, H. D., & Huber, R. (1997) · Nature · doi:10.1038/386463a0 · Cited by 2,257
Protein degradation and protection against misfolded or damaged proteins.
Goldberg, A. L. (2003) · Nature · doi:10.1038/nature02263 · Cited by 2,088
Breaking the chains: structure and function of the deubiquitinases
Komander, D., Clague, M. J., & Urbé, S. (2009) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2731 · Cited by 1,969
The resurgence of covalent drugs
Singh, J., Petter, R. C., Baillie, T. A., & Whitty, A. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3410 · Cited by 1,873
De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-κB signalling
Wertz, I. E., O'Rourke, K. M., Zhou, H., Eby, M., Aravind, L., Seshagiri, S., Wu, P., Wiesmann, C., Baker, R., Boone, D. L., et al. (2004) · Nature · doi:10.1038/nature02794 · Cited by 1,856
A genomic and functional inventory of deubiquitinating enzymes.
Nijman, S. M. B., Luna-Vargas, M. P. A., Velds, A., Brummelkamp, T. R., Dirac, A. M. G., Sixma, T. K., & Bernards, R. (2005) · Cell · doi:10.1016/j.cell.2005.11.007 · Cited by 1,854
Recognition and Processing of Ubiquitin-Protein Conjugates by the Proteasome
Finley, D. (2009) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.78.081507.101607 · Cited by 1,764
CAG expansions in a novel gene for Machado-Joseph disease at chromosome 14q32.1
Kawaguchi, Y., Okamoto, T., Taniwaki, M., Aizawa, M., Inoue, M., Katayama, S., Kawakami, H., Nakamura, S., Nishimura, M., Akiguchi, I., et al. (1994) · Nature Genetics · doi:10.1038/ng1194-221 · Cited by 1,753
Quantitative reactivity profiling predicts functional cysteines in proteomes
Weerapana, E., Wang, C., Simon, G. M., Richter, F., Khare, S., Dillon, M. B. D., Bachovchin, D. A., Mowen, K., Baker, D., & Cravatt, B. F. (2010) · Nature · doi:10.1038/nature09472 · Cited by 1,684
Delineation of prognostic biomarkers in prostate cancer
Dhanasekaran, S. M., Barrette, T. R., Ghosh, D., Shah, R., Varambally, S., Kurachi, K., Pienta, K. J., Rubin, M. A., & Chinnaiyan, A. M. (2001) · Nature · doi:10.1038/35090585 · Cited by 1,673
Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers
Shoba, G., Joy, D., Joseph, T., Majeed, M., Rajendran, R., & Srinivas, P. (1998) · Planta Medica · doi:10.1055/s-2006-957450 · Cited by 1,656
The 26S Proteasome: A Molecular Machine Designed for Controlled Proteolysis
Voges, D., Zwickl, P., & Baumeister, W. (1999) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.68.1.1015 · Cited by 1,608
Garraway, L. A., Widlund, H. R., Rubin, M. A., Getz, G., Berger, A. J., Ramaswamy, S., Beroukhim, R., Milner, D. A., Granter, S. R., Du, J., et al. (2005) · Nature · doi:10.1038/nature03664 · Cited by 1,548
Rapid degradation of a large fraction of newly synthesized proteins by proteasomes
Schubert, U., Antón, L. C., Gibbs, J., Norbury, C. C., Yewdell, J. W., & Bennink, J. R. (2000) · Nature · doi:10.1038/35008096 · Cited by 1,536
A multiubiquitin chain is confined to specific lysine in a targeted short-lived protein
Chau, V., Tobias, J. W., Bachmair, A., Marriott, D., Ecker, D. J., Gonda, D. K., & Varshavsky, A. (1989) · Science · doi:10.1126/science.2538923 · Cited by 1,535
Crystal Structure of the 20 S Proteasome from the Archaeon T. acidophilum at 3.4 Å Resolution
Löwe, J., Stock, D., Jap, B., Zwickl, P., Baumeister, W., & Huber, R. (1995) · Science · doi:10.1126/science.7725097 · Cited by 1,525
Ubiquitin: structures, functions, mechanisms
Pickart, C. M., & Eddins, M. J. (2004) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2004.09.019 · Cited by 1,407
Protein regulation by monoubiquitin
Hicke, L. (2001) · Nature Reviews Molecular Cell Biology · doi:10.1038/35056583 · Cited by 1,211
Hershko, A., Heller, H., Elias, S., & Ciechanover, A. (1983) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)82050-x · Cited by 1,160
Xu, P., Duong, D. M., Seyfried, N. T., Cheng, D., Xie, Y., Robert, J., Rush, J., Hochstrasser, M., Finley, D., & Peng, J. (2009) · Cell · doi:10.1016/j.cell.2009.01.041 · Cited by 1,136
Deubiquitination of p53 by HAUSP is an important pathway for p53 stabilization
Li, M., Chen, D., Shiloh, A., Luo, J., Nikolaev, A. Y., Qin, J., & Gu, W. (2002) · Nature · doi:10.1038/nature737 · Cited by 1,031
Role of Rpn11 Metalloprotease in Deubiquitination and Degradation by the 26 S Proteasome
Verma, R., Aravind, L., Oania, R., McDonald, W. H., Yates, J. R., Koonin, E. V., & Deshaies, R. J. (2002) · Science · doi:10.1126/science.1075898 · Cited by 1,000
Building ubiquitin chains: E2 enzymes at work
Ye, Y., & Rape, M. (2009) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2780 · Cited by 989
CYLD is a deubiquitinating enzyme that negatively regulates NF-κB activation by TNFR family members
Trompouki, E., Hatzivassiliou, E., Tsichritzis, T., Farmer, H., Ashworth, A., & Mosialos, G. (2003) · Nature · doi:10.1038/nature01803 · Cited by 961
BAP1 loss defines a new class of renal cell carcinoma
Peña-Llopis, S., Vega-Rubín-de-Celis, S., Liao, A., Leng, N., Pavía-Jiménez, A., Wang, S., Yamasaki, T., Zhrebker, L., Sivanand, S., Spence, P., et al. (2012) · Nature Genetics · doi:10.1038/ng.2323 · Cited by 959
Glickman, M. H., Rubin, D. M., Coux, O., Wefes, I., Pfeifer, G., Cjeka, Z., Baumeister, W., Fried, V. A., & Finley, D. (1998) · Cell · doi:10.1016/s0092-8674(00)81603-7 · Cited by 898
Enhancement of proteasome activity by a small-molecule inhibitor of USP14
Lee, B.-H., Lee, M. J., Park, S., Oh, D.-C., Elsasser, S., Chen, P.-C., Gartner, C., Dimova, N., Hanna, J., Gygi, S. P., et al. (2010) · Nature · doi:10.1038/nature09299 · Cited by 893
Pisha, E., Chai, H., Lee, I.-S., Chagwedera, T. E., Farnsworth, N. R., Cordell, G. A., Beecher, C. W. W., Fong, H. H. S., Kinghorn, A. D., Brown, D. M., et al. (1995) · Nature Medicine · doi:10.1038/nm1095-1046 · Cited by 886
Protein carbonylation, cellular dysfunction, and disease progression
Dalle-Donne, I., Aldini, G., Carini, M., Colombo, R., Rossi, R., & Milzani, A. (2006) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2006.tb00407.x · Cited by 831
Beclin1 Controls the Levels of p53 by Regulating the Deubiquitination Activity of USP10 and USP13
Liu, J., Xia, H., Kim, M., Xu, L., Li, Y., Zhang, L., Cai, Y., Norberg, H. V., Zhang, T., Furuya, T., et al. (2011) · Cell · doi:10.1016/j.cell.2011.08.037 · Cited by 820
p53 is regulated by the lysine demethylase LSD1
Huang, J., Sengupta, R., Espejo, A. B., Lee, M. G., Dorsey, J. A., Richter, M., Opravil, S., Shiekhattar, R., Bedford, M. T., Jenuwein, T., et al. (2007) · Nature · doi:10.1038/nature06092 · Cited by 807
McGill, G. G., Horstmann, M., Widlund, H. R., Du, J., Motyckova, G., Nishimura, E. K., Lin, Y.-L., Ramaswamy, S., Avery, W., Ding, H.-F., et al. (2002) · Cell · doi:10.1016/s0092-8674(02)00762-6 · Cited by 760
The RIDDLE Syndrome Protein Mediates a Ubiquitin-Dependent Signaling Cascade at Sites of DNA Damage
Stewart, G. S., Panier, S., Townsend, K., Al-Hakim, A. K., Kolas, N. K., Miller, E. S., Nakada, S., Ylanko, J., Olivarius, S., Mendez, M., et al. (2009) · Cell · doi:10.1016/j.cell.2008.12.042 · Cited by 758
Ubiquitylation and cell signaling
Haglund, K., & Dikic, I. (2005) · The EMBO Journal · doi:10.1038/sj.emboj.7600808 · Cited by 734
A cryptic protease couples deubiquitination and degradation by the proteasome
Yao, T., & Cohen, R. E. (2002) · Nature · doi:10.1038/nature01071 · Cited by 725
Jensen, D. E., Proctor, M., Marquis, S. T., Gardner, H. P., Ha, S. I., Chodosh, L. A., Ishov, A. M., Tommerup, N., Vissing, H., Sekido, Y., et al. (1998) · Oncogene · doi:10.1038/sj.onc.1201861 · Cited by 723
Bott, M., Brevet, M., Taylor, B. S., Shimizu, S., Ito, T., Wang, L., Creaney, J., Lake, R. A., Zakowski, M. F., Reva, B., et al. (2011) · Nature Genetics · doi:10.1038/ng.855 · Cited by 717
Multiple monoubiquitination of RTKs is sufficient for their endocytosis and degradation
Haglund, K., Sigismund, S., Polo, S., Szymkiewicz, I., Di Fiore, P. P., & Dikic, I. (2003) · Nature Cell Biology · doi:10.1038/ncb983 · Cited by 715
Curcumin: Getting Back to the Roots
SHISHODIA, S., SETHI, G., & AGGARWAL, B. B. (2005) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1352.010 · Cited by 715
A dynamic role of HAUSP in the p53-Mdm2 pathway
Li, M., Brooks, C. L., Kon, N., & Gu, W. (2004) · Molecular Cell · doi:10.1016/s1097-2765(04)00157-1 · Cited by 679 · cited 3×
“Other investigators have reported that cyclopentone PGs inhibit cellular DUB activities: UCHL3 was found to be inhibited by Δ12-PGJ2 (Li et al., 2004) and UCHL1 by 15Δ-PGJ2 (Liu et al.”
BackgroundRAP80 Targets BRCA1 to Specific Ubiquitin Structures at DNA Damage Sites
Sobhian, B., Shao, G., Lilli, D. R., Culhane, A. C., Moreau, L. A., Xia, B., Livingston, D. M., & Greenberg, R. A. (2007) · Science · doi:10.1126/science.1139516 · Cited by 674
Identification of the familial cylindromatosis tumour-suppressor gene
Bignell, G. R., Warren, W., Seal, S., Takahashi, M., Rapley, E., Barfoot, R., Green, H., Brown, C., Biggs, P. J., Lakhani, S. R., et al. (2000) · Nature Genetics · doi:10.1038/76006 · Cited by 666
Proteasome subunit Rpn13 is a novel ubiquitin receptor
Husnjak, K., Elsasser, S., Zhang, N., Chen, X., Randles, L., Shi, Y., Hofmann, K., Walters, K. J., Finley, D., & Dikic, I. (2008) · Nature · doi:10.1038/nature06926 · Cited by 660
Developing Irreversible Inhibitors of the Protein Kinase Cysteinome
Liu, Q., Sabnis, Y., Zhao, Z., Zhang, T., Buhrlage, S. J., Jones, L. H., & Gray, N. S. (2013) · Chemistry & Biology · doi:10.1016/j.chembiol.2012.12.006 · Cited by 652
USP10 Regulates p53 Localization and Stability by Deubiquitinating p53
Yuan, J., Luo, K., Zhang, L., Cheville, J. C., & Lou, Z. (2010) · Cell · doi:10.1016/j.cell.2009.12.032 · Cited by 637 · cited 1×
“6) (Yuan et al., 2010).”
Deubiquitinase USP9X stabilizes MCL1 and promotes tumour cell survival
Schwickart, M., Huang, X., Lill, J. R., Liu, J., Ferrando, R., French, D. M., Maecker, H., O’Rourke, K., Bazan, F., Eastham-Anderson, J., et al. (2010) · Nature · doi:10.1038/nature08646 · Cited by 628
Complete subunit architecture of the proteasome regulatory particle
Lander, G. C., Estrin, E., Matyskiela, M. E., Bashore, C., Nogales, E., & Martin, A. (2012) · Nature · doi:10.1038/nature10774 · Cited by 608
Chauhan, D., Tian, Z., Nicholson, B., Kumar, K. G. S., Zhou, B., Carrasco, R., McDermott, J. L., Leach, C. A., Fulcinniti, M., Kodrasov, M. P., et al. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.08.007 · Cited by 589
Chemistry-Based Functional Proteomics Reveals Novel Members of the Deubiquitinating Enzyme Family
Borodovsky, A., Ovaa, H., Kolli, N., Gan-Erdene, T., Wilkinson, K. D., Ploegh, H. L., & Kessler, B. M. (2002) · Chemistry & Biology · doi:10.1016/s1074-5521(02)00248-x · Cited by 588 · cited 2×
“OTUB enzymes (OTU domain-containing ubiquitin aldehydebinding proteins) constitute a subfamily of 14 DUBs characterized by an ovarian tumor (OTU) domain (Borodovsky et al., 2002; Balakirev et al., 2003).”
BackgroundThe Deubiquitinating Enzyme USP1 Regulates the Fanconi Anemia Pathway
Nijman, S. M. B., Huang, T. T., Dirac, A. M. G., Brummelkamp, T. R., Kerkhoven, R. M., D'Andrea, A. D., & Bernards, R. (2005) · Molecular Cell · doi:10.1016/j.molcel.2005.01.008 · Cited by 588
Regulation of monoubiquitinated PCNA by DUB autocleavage
Huang, T. T., Nijman, S. M. B., Mirchandani, K. D., Galardy, P. J., Cohn, M. A., Haas, W., Gygi, S. P., Ploegh, H. L., Bernards, R., & D'Andrea, A. D. (2006) · Nature Cell Biology · doi:10.1038/ncb1378 · Cited by 581
A20: linking a complex regulator of ubiquitylation to immunity and human disease
Ma, A., & Malynn, B. A. (2012) · Nature Reviews Immunology · doi:10.1038/nri3313 · Cited by 548
UBP43 (USP18) Specifically Removes ISG15 from Conjugated Proteins
Malakhov, M. P., Malakhova, O. A., Kim, K. I., Ritchie, K. J., & Zhang, D.-E. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m109078200 · Cited by 531
Thioredoxin Reductase Is Irreversibly Modified by Curcumin
Fang, J., Lu, J., & Holmgren, A. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m414645200 · Cited by 521
Smith, D. M., Chang, S.-C., Park, S., Finley, D., Cheng, Y., & Goldberg, A. L. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.06.033 · Cited by 521 · cited 2×
“…20S CP as well as utilizing the hydrolysis of ATP to drive the unwinding and translocation of ubiquitinated proteins through the narrow pore into the 20S CP for degradation (Smith et al., 2007; Martin et al., 2008; Rabl et al., 2008; Zhang et al., 2009; Maillard et al., 2011; Erales et al., 2012).”
BackgroundThe Structure of the Mammalian 20S Proteasome at 2.75 Å Resolution
Unno, M., Mizushima, T., Morimoto, Y., Tomisugi, Y., Tanaka, K., Yasuoka, N., & Tsukihara, T. (2002) · Structure · doi:10.1016/s0969-2126(02)00748-7 · Cited by 519
Borodovsky, A., Kessler, B. M., Casagrande, R., Overkleeft, H. S., Wilkinson, K. D., & Ploegh, H. L. (2001) · The EMBO Journal · doi:10.1093/emboj/20.18.5187 · Cited by 504
FAM/USP9x, a Deubiquitinating Enzyme Essential for TGFβ Signaling, Controls Smad4 Monoubiquitination
Dupont, S., Mamidi, A., Cordenonsi, M., Montagner, M., Zacchigna, L., Adorno, M., Martello, G., Stinchfield, M. J., Soligo, S., Morsut, L., et al. (2009) · Cell · doi:10.1016/j.cell.2008.10.051 · Cited by 494 · cited 1×
“In contrast, a recent study has suggested that Uch37/UCHL5 promotes the degradation of specific proteasome substrates, nitric oxide synthase and IκB-α (Mazumdar et al., 2010).”
Reversible targeting of noncatalytic cysteines with chemically tuned electrophiles
Serafimova, I. M., Pufall, M. A., Krishnan, S., Duda, K., Cohen, M. S., Maglathlin, R. L., McFarland, J. M., Miller, R. M., Frödin, M., & Taunton, J. (2012) · Nature Chemical Biology · doi:10.1038/nchembio.925 · Cited by 493
Inhibition of proteasome deubiquitinating activity as a new cancer therapy
D'Arcy, P., Brnjic, S., Olofsson, M. H., Fryknäs, M., Lindsten, K., De Cesare, M., Perego, P., Sadeghi, B., Hassan, M., Larsson, R., et al. (2011) · Nature Medicine · doi:10.1038/nm.2536 · Cited by 492
Self-citationEverett, R. D. (1997) · The EMBO Journal · doi:10.1093/emboj/16.7.1519 · Cited by 492
TNFAIP3 (A20) is a tumor suppressor gene in Hodgkin lymphoma and primary mediastinal B cell lymphoma
Schmitz, R., Hansmann, M.-L., Bohle, V., Martin-Subero, J. I., Hartmann, S., Mechtersheimer, G., Klapper, W., Vater, I., Giefing, M., Gesk, S., et al. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20090528 · Cited by 481
Cyld Inhibits Tumor Cell Proliferation by Blocking Bcl-3-Dependent NF-κB Signaling
Massoumi, R., Chmielarska, K., Hennecke, K., Pfeifer, A., & Fässler, R. (2006) · Cell · doi:10.1016/j.cell.2006.03.041 · Cited by 476
The ubiquitin-specific protease USP28 is required for MYC stability
Popov, N., Wanzel, M., Madiredjo, M., Zhang, D., Beijersbergen, R., Bernards, R., Moll, R., Elledge, S. J., & Eilers, M. (2007) · Nature Cell Biology · doi:10.1038/ncb1601 · Cited by 474
Ling, Y.-H., Liebes, L., Zou, Y., & Perez-Soler, R. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m302559200 · Cited by 458
Editing of ubiquitin conjugates by an isopeptidase in the 26S proteasome
Lam, Y. A., Xu, W., DeMartino, G. N., & Cohen, R. E. (1997) · Nature · doi:10.1038/385737a0 · Cited by 455
Deubiquitinases in cancer: new functions and therapeutic options
Fraile, J. M., Quesada, V, Rodríguez, D., Freije, J. M. P., & López-Otín, C. (2012) · Oncogene · doi:10.1038/onc.2011.443 · Cited by 453
A Deubiquitinase That Regulates Type I Interferon Production
Kayagaki, N., Phung, Q., Chan, S., Chaudhari, R., Quan, C., O'Rourke, K. M., Eby, M., Pietras, E., Cheng, G., Bazan, J. F., et al. (2007) · Science · doi:10.1126/science.1145918 · Cited by 452
Interferon induces a 15-kilodalton protein exhibiting marked homology to ubiquitin.
Haas, A. L., Ahrens, P., Bright, P. M., & Ankel, H. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)60961-5 · Cited by 450
The interferon-inducible 15-kDa ubiquitin homolog conjugates to intracellular proteins.
Loeb, K. R., & Haas, A. L. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)42585-9 · Cited by 435
Bochtler, M., Ditzel, L., Groll, M., Hartmann, C., & Huber, R. (1999) · Annual Review of Biophysics and Biomolecular Structure · doi:10.1146/annurev.biophys.28.1.295 · Cited by 435
UBP43 is a novel regulator of interferon signaling independent of its ISG15 isopeptidase activity
Malakhova, O. A., Kim, K., Luo, J., Zou, W., Kumar, K. S., Fuchs, S. Y., Shuai, K., & Zhang, D. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601149 · Cited by 431
Structure and mechanisms of the proteasome‐associated deubiquitinating enzyme USP14
Hu, M., Li, P., Song, L., Jeffrey, P. D., Chernova, T. A., Wilkinson, K. D., Cohen, R. E., & Shi, Y. (2005) · The EMBO Journal · doi:10.1038/sj.emboj.7600832 · Cited by 429
Eichhorn, P. J. A., Rodón, L., Gonzàlez-Juncà, A., Dirac, A., Gili, M., Martínez-Sáez, E., Aura, C., Barba, I., Peg, V., Prat, A., et al. (2012) · Nature Medicine · doi:10.1038/nm.2619 · Cited by 409
Activity-Based Chemical Proteomics Accelerates Inhibitor Development for Deubiquitylating Enzymes
Altun, M., Kramer, H. B., Willems, L. I., McDermott, J. L., Leach, C. A., Goldenberg, S. J., Kumar, K. G. S., Konietzny, R., Fischer, R., Kogan, E., et al. (2011) · Chemistry & Biology · doi:10.1016/j.chembiol.2011.08.018 · Cited by 402
Kapuria, V., Peterson, L. F., Fang, D., Bornmann, W. G., Talpaz, M., & Donato, N. J. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-1530 · Cited by 383
Zhao, Y., Lang, G., Ito, S., Bonnet, J., Metzger, E., Sawatsubashi, S., Suzuki, E., Le Guezennec, X., Stunnenberg, H. G., Krasnov, A., et al. (2008) · Molecular Cell · doi:10.1016/j.molcel.2007.12.011 · Cited by 382
Mechanism of Gate Opening in the 20S Proteasome by the Proteasomal ATPases
Rabl, J., Smith, D. M., Yu, Y., Chang, S.-C., Goldberg, A. L., & Cheng, Y. (2008) · Molecular Cell · doi:10.1016/j.molcel.2008.03.004 · Cited by 382
Disruption of HAUSP gene stabilizes p53.
Cummins, J. M., Rago, C., Kohli, M., Kinzler, K. W., Lengauer, C., & Vogelstein, B. (2004) · Nature · doi:10.1038/nature02501 · Cited by 379
Activation of Mitochondria and Release of Mitochondrial Apoptogenic Factors by Betulinic Acid
Fulda, S., Scaffidi, C., Susin, S. A., Krammer, P. H., Kroemer, G., Peter, M. E., & Debatin, K.-M. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.51.33942 · Cited by 369
The isopeptidase USP2a regulates the stability of fatty acid synthase in prostate cancer
Graner, E., Tang, D., Rossi, S., Baron, A., Migita, T., Weinstein, L. J., Lechpammer, M., Huesken, D., Zimmermann, J., Signoretti, S., et al. (2004) · Cancer Cell · doi:10.1016/s1535-6108(04)00055-8 · Cited by 367
Anaphase initiation is regulated by antagonistic ubiquitination and deubiquitination activities
Stegmeier, F., Rape, M., Draviam, V. M., Nalepa, G., Sowa, M. E., Ang, X. L., McDonald III, E. R., Li, M. Z., Hannon, G. J., Sorger, P. K., et al. (2007) · Nature · doi:10.1038/nature05694 · Cited by 367
The inherent instability of mutant p53 is alleviated by Mdm2 or p16 INK4a loss
Terzian, T., Suh, Y.-A., Iwakuma, T., Post, S. M., Neumann, M., Lang, G. A., Van Pelt, C. S., & Lozano, G. (2008) · Genes & Development · doi:10.1101/gad.1662908 · Cited by 357
Deubiquitinating Enzyme Ubp6 Functions Noncatalytically to Delay Proteasomal Degradation
Hanna, J., Hathaway, N. A., Tone, Y., Crosas, B., Elsasser, S., Kirkpatrick, D. S., Leggett, D. S., Gygi, S. P., King, R. W., & Finley, D. (2006) · Cell · doi:10.1016/j.cell.2006.07.038 · Cited by 354
Rad23 and Rpn10 Serve as Alternative Ubiquitin Receptors for the Proteasome
Elsasser, S., Chandler-Militello, D., Müller, B., Hanna, J., & Finley, D. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m404020200 · Cited by 349
Wang, Q., Mora-Jensen, H., Weniger, M. A., Perez-Galan, P., Wolford, C., Hai, T., Ron, D., Chen, W., Trenkle, W., Wiestner, A., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0807611106 · Cited by 343
Proteasome recruitment and activation of the Uch37 deubiquitinating enzyme by Adrm1
Yao, T., Song, L., Xu, W., DeMartino, G. N., Florens, L., Swanson, S. K., Washburn, M. P., Conaway, R. C., Conaway, J. W., & Cohen, R. E. (2006) · Nature Cell Biology · doi:10.1038/ncb1460 · Cited by 336
Aurora kinases link chromosome segregation and cell division to cancer susceptibility
Meraldi, P., Honda, R., & Nigg, E. A. (2004) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2003.11.006 · Cited by 336
Ventii, K. H., Devi, N. S., Friedrich, K. L., Chernova, T. A., Tighiouart, M., Van Meir, E. G., & Wilkinson, K. D. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-0365 · Cited by 334
Albumin-catalyzed metabolism of prostaglandin D2. Identification of products formed in vitro.
Fitzpatrick, F. A., & Wynalda, M. A. (1983) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)44287-6 · Cited by 328
Application of the Hard and Soft, Acids and Bases (HSAB) Theory to Toxicant–Target Interactions
LoPachin, R. M., Gavin, T., DeCaprio, A., & Barber, D. S. (2012) · Chemical Research in Toxicology · doi:10.1021/tx2003257 · Cited by 326
A Role for the Deubiquitinating Enzyme USP28 in Control of the DNA-Damage Response
Zhang, D., Zaugg, K., Mak, T. W., & Elledge, S. J. (2006) · Cell · doi:10.1016/j.cell.2006.06.039 · Cited by 326
Small-molecule inhibitor of USP7/HAUSP ubiquitin protease stabilizes and activates p53 in cells
Colland, F., Formstecher, E., Jacq, X., Reverdy, C., Planquette, C., Conrath, S., Trouplin, V., Bianchi, J., Aushev, V. N., Camonis, J., et al. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-0097 · Cited by 321
Chen, G., Gharib, T. G., Huang, C.-C., Thomas, D. G., Shedden, K., Taylor, J. M. G., Kardia, S. L. R., Misek, D. E., Giordano, T. J., Iannettoni, M. D., et al. (2002) · PubMed · Cited by 317
The deubiquitinase USP9X suppresses pancreatic ductal adenocarcinoma
Initiative, A. P. C. G., Pérez-Mancera, P. A., Rust, A. G., van der Weyden, L., Kristiansen, G., Li, A., Sarver, A. L., Silverstein, K. A. T., Grützmann, R., Aust, D., et al. (2012) · Nature · doi:10.1038/nature11114 · Cited by 316
Lin, Z., Yang, H., Kong, Q., Li, J., Lee, S.-M., Gao, B., Dong, H., Wei, J., Song, J., Zhang, D. D., et al. (2012) · Molecular Cell · doi:10.1016/j.molcel.2012.03.024 · Cited by 315
USP6 (Tre2) Fusion Oncogenes in Aneurysmal Bone Cyst
Oliveira, A. M., Hsi, B.-L., Weremowicz, S., Rosenberg, A. E., Cin, P. D., Joseph, N., Bridge, J. A., Perez-Atayde, A. R., & Fletcher, J. A. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-2827 · Cited by 313
Tian, Z., D’Arcy, P., Wang, X., Ray, A., Tai, Y.-T., Hu, Y., Carrasco, R. D., Richardson, P., Linder, S., Chauhan, D., et al. (2014) · Blood · doi:10.1182/blood-2013-05-500033 · Cited by 311
Self-citationWhen ubiquitin meets ubiquitin receptors: a signalling connection
Di Fiore, P. P., Polo, S., & Hofmann, K. (2003) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1124 · Cited by 309
CP110, a Cell Cycle-Dependent CDK Substrate, Regulates Centrosome Duplication in Human Cells
Chen, Z., Indjeian, V. B., McManus, M., Wang, L., & Dynlacht, B. D. (2002) · Developmental Cell · doi:10.1016/s1534-5807(02)00258-7 · Cited by 309
TNFAIP3/A20 functions as a novel tumor suppressor gene in several subtypes of non-Hodgkin lymphomas
Honma, K., Tsuzuki, S., Nakagawa, M., Tagawa, H., Nakamura, S., Morishima, Y., & Seto, M. (2009) · Blood · doi:10.1182/blood-2008-12-194852 · Cited by 305
Regulation of cell cycle progression and gene expression by H2A deubiquitination
Joo, H.-Y., Zhai, L., Yang, C., Nie, S., Erdjument-Bromage, H., Tempst, P., Chang, C., & Wang, H. (2007) · Nature · doi:10.1038/nature06256 · Cited by 286
ClpX(P) Generates Mechanical Force to Unfold and Translocate Its Protein Substrates
Maillard, R. A., Chistol, G., Sen, M., Righini, M., Tan, J., Kaiser, C. M., Hodges, C., Martin, A., & Bustamante, C. (2011) · Cell · doi:10.1016/j.cell.2011.04.010 · Cited by 286
The ubiquitin-mediated proteolytic pathway: Mode of action and clinical implications
Ciechanover, A., Orian, A., & Schwartz, A. L. (2000) · Journal of Cellular Biochemistry · doi:10.1002/(sici)1097-4644(2000)77:34+<40::aid-jcb9>3.0.co;2-6 · Cited by 282
Schwartz, P. A., Kuzmic, P., Solowiej, J., Bergqvist, S., Bolanos, B., Almaden, C., Nagata, A., Ryan, K., Feng, J., Dalvie, D., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1313733111 · Cited by 281
The deubiquitinating enzyme USP2a regulates the p53 pathway by targeting Mdm2
Stevenson, L. F., Sparks, A., Allende‐Vega, N., Xirodimas, D. P., Lane, D. P., & Saville, M. K. (2007) · The EMBO Journal · doi:10.1038/sj.emboj.7601567 · Cited by 280
Gao, L., Wang, J., Sekhar, K. R., Yin, H., Yared, N. F., Schneider, S. N., Sasi, S., Dalton, T. P., Anderson, M. E., Chan, J. Y., et al. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m607622200 · Cited by 277
Dong, Y., Hakimi, M.-A., Chen, X., Kumaraswamy, E., Cooch, N. S., Godwin, A. K., & Shiekhattar, R. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00424-6 · Cited by 276
Regulation of DNA repair by ubiquitylation
Huang, T. T., & D'Andrea, A. D. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1908 · Cited by 275
Otubains: a new family of cysteine proteases in the ubiquitin pathway
Balakirev, M. Y., Tcherniuk, S. O., Jaquinod, M., & Chroboczek, J. (2003) · EMBO reports · doi:10.1038/sj.embor.embor824 · Cited by 275
Discovery of specific inhibitors of human USP7/HAUSP deubiquitinating enzyme.
Reverdy, C., Conrath, S., Lopez, R., Planquette, C., Atmanene, C., Collura, V., Harpon, J., Battaglia, V., Vivat, V., Sippl, W., et al. (2012) · Chemistry & Biology · doi:10.1016/j.chembiol.2012.02.007 · Cited by 270
Point mutations in the RUNX1/AML1 gene: another actor in RUNX leukemia
Osato, M. (2004) · Oncogene · doi:10.1038/sj.onc.1207779 · Cited by 268
Wilson, S. M., Bhattacharyya, B., Rachel, R. A., Coppola, V., Tessarollo, L., Householder, D. B., Fletcher, C. F., Miller, R. J., Copeland, N. G., & Jenkins, N. A. (2002) · Nature Genetics · doi:10.1038/ng1006 · Cited by 265
Row, P. E., Prior, I. A., McCullough, J., Clague, M. J., & Urbé, S. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m512615200 · Cited by 264
Regulation of NF‐κB by deubiquitinases
Harhaj, E. W., & Dixit, V. M. (2012) · Immunological Reviews · doi:10.1111/j.1600-065x.2012.01100.x · Cited by 260
Hussain, S., Zhang, Y., & Galardy, P. (2009) · Cell Cycle · doi:10.4161/cc.8.11.8739 · Cited by 260
Pore loops of the AAA+ ClpX machine grip substrates to drive translocation and unfolding
Martin, A., Baker, T. A., & Sauer, R. T. (2008) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1503 · Cited by 260
Lysine 63‐linked polyubiquitin chain may serve as a targeting signal for the 26S proteasome
Saeki, Y., Kudo, T., Sone, T., Kikuchi, Y., Yokosawa, H., Toh‐e, A., & Tanaka, K. (2009) · The EMBO Journal · doi:10.1038/emboj.2008.305 · Cited by 260
Liu, Y., Lashuel, H. A., Choi, S., Xing, X., Case, A., Ni, J., Yeh, L.-A., Cuny, G. D., Stein, R. L., & Lansbury, P. T. (2003) · Chemistry & Biology · doi:10.1016/j.chembiol.2003.08.010 · Cited by 256
Selective protein degradation: A journey's end within the proteasome
Jentsch, S., & Schlenker, S. (1995) · Cell · doi:10.1016/0092-8674(95)90021-7 · Cited by 254
A novel proteasome interacting protein recruits the deubiquitinating enzyme UCH37 to 26S proteasomes
Hamazaki, J., Iemura, S., Natsume, T., Yashiroda, H., Tanaka, K., & Murata, S. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601338 · Cited by 254
JAMM: A Metalloprotease-Like Zinc Site in the Proteasome and Signalosome
Ambroggio, X. I., Rees, D. C., & Deshaies, R. J. (2003) · PLoS Biology · doi:10.1371/journal.pbio.0020002 · Cited by 247
Novak, U., Rinaldi, A., Kwee, I., Nandula, S. V., Rancoita, P. M. V., Compagno, M., Cerri, M., Rossi, D., Murty, V. V., Zucca, E., et al. (2009) · Blood · doi:10.1182/blood-2008-08-174110 · Cited by 246
Nakagawa, T., Kajitani, T., Togo, S., Masuko, N., Ohdan, H., Hishikawa, Y., Koji, T., Matsuyama, T., Ikura, T., Muramatsu, M., et al. (2008) · Genes & Development · doi:10.1101/gad.1609708 · Cited by 245
Yu.Amerik, A. (1997) · The EMBO Journal · doi:10.1093/emboj/16.16.4826 · Cited by 244
Discovery, characterization and SAR of gambogic acid as a potent apoptosis inducer by a HTS assay
Zhang, H.-Z., Kasibhatla, S., Wang, Y., Herich, J., Guastella, J., Tseng, B., Drewe, J., & Cai, S. X. (2004) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2003.11.013 · Cited by 239
Trimming of Ubiquitin Chains by Proteasome-associated Deubiquitinating Enzymes
Lee, M. J., Lee, B.-H., Hanna, J., King, R. W., & Finley, D. (2011) · Molecular & Cellular Proteomics · doi:10.1074/mcp.r110.003871 · Cited by 238
Yi, T., Yi, Z., Cho, S.-G., Luo, J., Pandey, M. K., Aggarwal, B. B., & Liu, M. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5944 · Cited by 237
hRpn13/ADRM1/GP110 is a novel proteasome subunit that binds the deubiquitinating enzyme, UCH37
Qiu, X., Ouyang, S., Li, C., Miao, S., Wang, L., & Goldberg, A. L. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601450 · Cited by 234
Zwickl, P., Grziwa, A., Puehler, G., Dahlmann, B., Lottspeich, F., & Baumeister, W. (1992) · Biochemistry · doi:10.1021/bi00119a004 · Cited by 232
Suppression of Cancer Cell Growth by Promoting Cyclin D1 Degradation
Shan, J., Zhao, W., & Gu, W. (2009) · Molecular Cell · doi:10.1016/j.molcel.2009.10.018 · Cited by 229
Synthesis, cellular evaluation, and mechanism of action of piperlongumine analogs
Adams, D. J., Dai, M., Pellegrino, G., Wagner, B. K., Stern, A. M., Shamji, A. F., & Schreiber, S. L. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1212802109 · Cited by 228
Koulich, E., Li, X., & DeMartino, G. N. (2008) · Molecular Biology of the Cell · doi:10.1091/mbc.e07-10-1040 · Cited by 223
Erdal, H., Berndtsson, M., Castro, J., Brunk, U., Shoshan, M. C., & Linder, S. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0408592102 · Cited by 218
Self-citationTauriello, D. V. F., Haegebarth, A., Kuper, I., Edelmann, M. J., Henraat, M., Canninga-van Dijk, M. R., Kessler, B. M., Clevers, H., & Maurice, M. M. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.01.035 · Cited by 217
Shiraki, T., Kamiya, N., Shiki, S., Kodama, T. S., Kakizuka, A., & Jingami, H. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m500901200 · Cited by 217
Shao, G., Lilli, D. R., Patterson-Fortin, J., Coleman, K. A., Morrissey, D. E., & Greenberg, R. A. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0807485106 · Cited by 217
RNF20 and USP44 Regulate Stem Cell Differentiation by Modulating H2B Monoubiquitylation
Fuchs, G., Shema, E., Vesterman, R., Kotler, E., Wolchinsky, Z., Wilder, S., Golomb, L., Pribluda, A., Zhang, F., Haj-Yahya, M., et al. (2012) · Molecular Cell · doi:10.1016/j.molcel.2012.05.023 · Cited by 216
Chen, J., Dexheimer, T. S., Ai, Y., Liang, Q., Villamil, M. A., Inglese, J., Maloney, D. J., Jadhav, A., Simeonov, A., & Zhuang, Z. (2011) · Chemistry & Biology · doi:10.1016/j.chembiol.2011.08.014 · Cited by 214
NF-κB Suppression by the Deubiquitinating Enzyme Cezanne
Enesa, K., Zakkar, M., Chaudhury, H., Luong, L. A., Rawlinson, L., Mason, J. C., Haskard, D. O., Dean, J. L. E., & Evans, P. C. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m708690200 · Cited by 213
Misaghi, S., Ottosen, S., Izrael-Tomasevic, A., Arnott, D., Lamkanfi, M., Lee, J., Liu, J., O'Rourke, K., Dixit, V. M., & Wilson, A. C. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.01517-08 · Cited by 212
Peth, A., Besche, H. C., & Goldberg, A. L. (2009) · Molecular Cell · doi:10.1016/j.molcel.2009.11.015 · Cited by 211
Regulation of NF-κB signaling by the A20 deubiquitinase
Shembade, N., & Harhaj, E. W. (2012) · Cellular & Molecular Immunology · doi:10.1038/cmi.2011.59 · Cited by 211
Maytal-Kivity, V., Reis, N., Hofmann, K., & Glickman, M. H. (2002) · BMC Biochemistry · doi:10.1186/1471-2091-3-28 · Cited by 209
Lin, Z., Yang, H., Tan, C., Li, J., Liu, Z., Quan, Q., Kong, S., Ye, J., Gao, B., & Fang, D. (2013) · Cell Reports · doi:10.1016/j.celrep.2013.11.029 · Cited by 207
Inhibition of p97-dependent Protein Degradation by Eeyarestatin I
Wang, Q., Li, L., & Ye, Y. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m708347200 · Cited by 205
Amslinger, S. (2010) · ChemMedChem · doi:10.1002/cmdc.200900499 · Cited by 204
Dayal, S., Sparks, A., Jacob, J., Allende-Vega, N., Lane, D. P., & Saville, M. K. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m805871200 · Cited by 199
Emerging roles of deubiquitinases in cancer‐associated pathways
Sacco, J. J., Coulson, J. M., Clague, M. J., & Urbé, S. (2010) · IUBMB Life · doi:10.1002/iub.300 · Cited by 196
VHL protein‐interacting deubiquitinating enzyme 2 deubiquitinates and stabilizes HIF‐1α
Li, Z., Wang, D., Messing, E. M., & Wu, G. (2005) · EMBO reports · doi:10.1038/sj.embor.7400377 · Cited by 196
Positive regulation of p53 stability and activity by the deubiquitinating enzyme Otubain 1
Sun, X., Challagundla, K. B., & Dai, M. (2012) · The EMBO Journal · doi:10.1038/emboj.2011.434 · Cited by 195
Flügel, D., Görlach, A., & Kietzmann, T. (2012) · Blood · doi:10.1182/blood-2011-08-375014 · Cited by 191
USP15 is a deubiquitylating enzyme for receptor-activated SMADs
Inui, M., Manfrin, A., Mamidi, A., Martello, G., Morsut, L., Soligo, S., Enzo, E., Moro, S., Polo, S., Dupont, S., et al. (2011) · Nature Cell Biology · doi:10.1038/ncb2346 · Cited by 190
The fat facets gene is required for Drosophila eye and embryo development
Fischer-Vize, J. A., Rubin, G. M., & Lehmann, R. (1992) · Development · doi:10.1242/dev.116.4.985 · Cited by 188
Selective dual inhibitors of the cancer-related deubiquitylating proteases USP7 and USP47.
Weinstock, J., Wu, J., Cao, P., Kingsbury, W. D., McDermott, J. L., Kodrasov, M. P., McKelvey, D. M., Suresh Kumar, K. G., Goldenberg, S. J., Mattern, M. R., et al. (2012) · ACS Medicinal Chemistry Letters · doi:10.1021/ml200276j · Cited by 187
Wang, D., Fang, L., Li, P., Sun, L., Fan, J., Zhang, Q., Luo, R., Liu, X., Li, K., Chen, H., et al. (2011) · Journal of Virology · doi:10.1128/jvi.02589-10 · Cited by 186
Wee, S., Geyer, R. K., Toda, T., & Wolf, D. A. (2005) · Nature Cell Biology · doi:10.1038/ncb1241 · Cited by 183
Regulation of proteolysis by human deubiquitinating enzymes
Eletr, Z. M., & Wilkinson, K. D. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2013.06.027 · Cited by 183
Li, S., Zheng, H., Mao, A.-P., Zhong, B., Li, Y., Liu, Y., Gao, Y., Ran, Y., Tien, P., & Shu, H.-B. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.074971 · Cited by 181
Pühler, G., Weinkauf, S., Bachmann, L., Müller, S., Engel, A., Hegerl, R., & Baumeister, W. (1992) · The EMBO Journal · doi:10.1002/j.1460-2075.1992.tb05206.x · Cited by 178
Alwan, H. A. J., van Zoelen, E. J. J., & van Leeuwen, J. E. M. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m301326200 · Cited by 177
The polyglutamine neurodegenerative protein ataxin 3 regulates aggresome formation
Burnett, B. G., & Pittman, R. N. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407252102 · Cited by 176
Ubiquitin‐specific proteases 7 and 11 modulate Polycomb regulation of the INK4a tumour suppressor
Maertens, G. N., Messaoudi, S. E., Elderkin, S., Hiom, K. J., & Peters, G. G. (2010) · The EMBO Journal · doi:10.1038/emboj.2010.129 · Cited by 175
USP3 inhibits type I interferon signaling by deubiquitinating RIG-I-like receptors
Cui, J., Song, Y., Li, Y., Zhu, Q., Tan, P., Qin, Y., Wang, H. Y., & Wang, R.-F. (2014) · Cell Research · doi:10.1038/cr.2013.170 · Cited by 174
UBPY: a growth‐regulated human ubiquitin isopeptidase
Naviglio, S., Matteucci, C., Matoskova, B., Nagase, T., Nomura, N., Di Fiore, P. P., & Draetta, G. F. (1998) · The EMBO Journal · doi:10.1093/emboj/17.12.3241 · Cited by 174
Ishii, T., Sakurai, T., Usami, H., & Uchida, K. (2005) · Biochemistry · doi:10.1021/bi051336u · Cited by 173
Li, Z., Na, X., Wang, D., Schoen, S. R., Messing, E. M., & Wu, G. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m108269200 · Cited by 171
The Deubiquitinase USP28 Stabilizes LSD1 and Confers Stem-Cell-like Traits to Breast Cancer Cells
Wu, Y., Wang, Y., Yang, X. H., Kang, T., Zhao, Y., Wang, C., Evers, B. M., & Zhou, B. P. (2013) · Cell Reports · doi:10.1016/j.celrep.2013.08.030 · Cited by 168
Buckley, D. L., & Crews, C. M. (2014) · Angewandte Chemie International Edition · doi:10.1002/anie.201307761 · Cited by 168
USP44 regulates centrosome positioning to prevent aneuploidy and suppress tumorigenesis
Zhang, Y., Foreman, O., Wigle, D. A., Kosari, F., Vasmatzis, G., Salisbury, J. L., van Deursen, J., & Galardy, P. J. (2012) · Journal of Clinical Investigation · doi:10.1172/jci63084 · Cited by 168
The Lysine 48 and Lysine 63 Ubiquitin Conjugates Are Processed Differently by the 26 S Proteasome
Jacobson, A. D., Zhang, N., Xu, P., Han, K.-J., Noone, S. M., Peng, J., & Liu, C. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.052928 · Cited by 167
A ubiquitin C-terminal isopeptidase that acts on polyubiquitin chains. Role in protein degradation.
Hadari, T., Warms, J. V., Rose, I. A., & Hershko, A. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)48343-3 · Cited by 164
Moos, P. J., Edes, K., Cassidy, P., Massuda, E., & Fitzpatrick, F. A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m211134200 · Cited by 163
Network Analyses Reveal Pervasive Functional Regulation Between Proteases in the Human Protease Web
Fortelny, N., Cox, J. H., Kappelhoff, R., Starr, A. E., Lange, P. F., Pavlidis, P., & Overall, C. M. (2014) · PLoS Biology · doi:10.1371/journal.pbio.1001869 · Cited by 163
Tanaka, K., Waxman, L., & Goldberg, A. L. (1983) · The Journal of cell biology · doi:10.1083/jcb.96.6.1580 · Cited by 163
Complementary Roles for Rpn11 and Ubp6 in Deubiquitination and Proteolysis by the Proteasome
Guterman, A., & Glickman, M. H. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m307050200 · Cited by 161
USP33 regulates centrosome biogenesis via deubiquitination of the centriolar protein CP110
Li, J., D’Angiolella, V., Seeley, E. S., Kim, S., Kobayashi, T., Fu, W., Campos, E. I., Pagano, M., & Dynlacht, B. D. (2013) · Nature · doi:10.1038/nature11941 · Cited by 161
A Novel Type of Deubiquitinating Enzyme
Evans, P. C., Smith, T. S., Lai, M.-J., Williams, M. G., Burke, D. F., Heyninck, K., Kreike, M. M., Beyaert, R., Blundell, T. L., & Kilshaw, P. J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m301863200 · Cited by 161
Thioredoxin as a Molecular Target of Cyclopentenone Prostaglandins
Shibata, T., Yamada, T., Ishii, T., Kumazawa, S., Nakamura, H., Masutani, H., Yodoi, J., & Uchida, K. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m303690200 · Cited by 161
Schoenfeld, A. R., Apgar, S., Dolios, G., Wang, R., & Aaronson, S. A. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.17.7444-7455.2004 · Cited by 160
The ER‐resident ubiquitin‐specific protease 19 participates in the UPR and rescues ERAD substrates
Hassink, G. C., Zhao, B., Sompallae, R., Altun, M., Gastaldello, S., Zinin, N. V., Masucci, M. G., & Lindsten, K. (2009) · EMBO reports · doi:10.1038/embor.2009.69 · Cited by 159
Wu, Z.-Q., Guo, Q.-L., You, Q.-D., Zhao, L., & Gu, H.-Y. (2004) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.27.1769 · Cited by 158
Glinsky, G. V. (2006) · Cell Cycle · doi:10.4161/cc.5.11.2796 · Cited by 158
USP8 Is a Novel Target for Overcoming Gefitinib Resistance in Lung Cancer
Byun, S., Lee, S., Lee, J., Jeong, C., Farrand, L., Lim, S., Reddy, K., Kim, J. Y., Lee, M., Lee, H. J., et al. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-3696 · Cited by 157
An arginine/lysine‐rich motif is crucial for VCP/p97‐mediated modulation of ataxin‐3 fibrillogenesis
Boeddrich, A., Gaumer, S., Haacke, A., Tzvetkov, N., Albrecht, M., Evert, B. O., Müller, E. C., Lurz, R., Breuer, P., Schugardt, N., et al. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601043 · Cited by 157
Qiu, X., & Goldberg, A. L. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.232580999 · Cited by 156
The deubiquitinase USP28 controls intestinal homeostasis and promotes colorectal cancer
Diefenbacher, M. E., Popov, N., Blake, S. M., Schülein‐Völk, C., Nye, E. L., Spencer‐Dene, B., Jaenicke, L. A., Eilers, M., & Behrens, A. (2014) · Journal of Clinical Investigation · doi:10.1172/jci73733 · Cited by 156
Tomko, R. J., Funakoshi, M., Schneider, K., Wang, J., & Hochstrasser, M. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.02.035 · Cited by 154
Hetfeld, B. K. J., Helfrich, A., Kapelari, B., Scheel, H., Hofmann, K., Guterman, A., Glickman, M. H., Schade, R., Kloetzel, P., & Dubiel, W. (2005) · Current Biology · doi:10.1016/j.cub.2005.05.059 · Cited by 153
Nagai, H., Noguchi, T., Homma, K., Katagiri, K., Takeda, K., Matsuzawa, A., & Ichijo, H. (2009) · Molecular Cell · doi:10.1016/j.molcel.2009.10.016 · Cited by 147
The Ubiquitin-Specific Protease USP34 Regulates Axin Stability and Wnt/β-Catenin Signaling
Lui, T. T. H., Lacroix, C., Ahmed, S. M., Goldenberg, S. J., Leach, C. A., Daulat, A. M., & Angers, S. (2011) · Molecular and Cellular Biology · doi:10.1128/mcb.01094-10 · Cited by 147
Phosphorylation-dependent activity of the deubiquitinase DUBA
Huang, O. W., Ma, X., Yin, J., Flinders, J., Maurer, T., Kayagaki, N., Phung, Q. T., Bosanac, I., Arnott, D. P., Dixit, V. M., et al. (2012) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.2206 · Cited by 145
Histone H2B monoubiquitination: roles to play in human malignancy
Cole, A. J., Clifton-Bligh, R. J., & Marsh, D. J. (2014) · Endocrine Related Cancer · doi:10.1530/erc-14-0185 · Cited by 144
Cited by
Deubiquitylating enzymes and drug discovery: emerging opportunities
Harrigan, J. A., Jacq, X., Martin, N. M., & Jackson, S. P. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.152 · Cited by 940
The role of ubiquitination in tumorigenesis and targeted drug discovery
Deng, L., Meng, T., Chen, L., Wei, W., & Wang, P. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-0107-0 · Cited by 744
Ubiquitination and deubiquitination in cancer: from mechanisms to novel therapeutic approaches
Liu, F., Chen, J., Li, K., Li, H., Zhu, Y., Zhai, Y., Lu, B., Fan, Y., Liu, Z., Chen, X., et al. (2024) · Molecular Cancer · doi:10.1186/s12943-024-02046-3 · Cited by 326
Li, D., Wang, Y., Dong, C., Chen, T., Dong, A., Ren, J., Li, W., Shu, G., Yang, J., Shen, W., et al. (2023) · Oncogene · doi:10.1038/s41388-022-02537-x · Cited by 316
Small-Molecule Modulation of Protein Homeostasis
Burslem, G. M., & Crews, C. M. (2017) · Chemical Reviews · doi:10.1021/acs.chemrev.7b00077 · Cited by 283
Metadata
- Authors
- D'Arcy, P., Wang, X., & Linder, S.
- Venue
- Pharmacology & Therapeutics
- Publisher
- Elsevier BV
- Published
- 2015-03
- Volume
- 147
- Pages
- 32-54
- ISSN
- 0163-7258 (ISSN-L)
- OpenAlex
- W2139592339
- Cited by
- 310
- References
- 318
- FWCI
- 7.79
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.